Your browser doesn't support javascript.
loading
Utility of natriuretic peptides to assess and manage patients with heart failure receiving angiotensin receptor blocker/neprilysin inhibitor therapy.
Maisel, Alan S; Daniels, Lori B; Anand, Inder S; McCullough, Peter A; Chow, Sheryl L.
Affiliation
  • Maisel AS; a Coronary Care Unit and Heart Failure Program , Veterans Affairs San Diego Healthcare System , San Diego , CA , USA.
  • Daniels LB; b Sulpizio Cardiovascular Center , University of California , San Diego, La Jolla , CA , USA.
  • Anand IS; c Department of Medicine, University of Minnesota Medical School and VA Medical Center , Minneapolis , MN , USA.
  • McCullough PA; d Baylor Heart and Vascular Institute, and Baylor Jack and Jane Hamilton Heart and Vascular Hospital , Baylor University Medical Center , Dallas , TX , USA.
  • Chow SL; e Preventive Cardiology & Advanced Lipidology Clinic , The Heart Hospital Baylor Plano , Plano , TX , USA.
Postgrad Med ; 130(3): 299-307, 2018 Apr.
Article in En | MEDLINE | ID: mdl-29596012
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neprilysin / Natriuretic Peptide, Brain / Angiotensin Receptor Antagonists / Heart Failure Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Postgrad Med Year: 2018 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neprilysin / Natriuretic Peptide, Brain / Angiotensin Receptor Antagonists / Heart Failure Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Postgrad Med Year: 2018 Type: Article Affiliation country: United States